Compared to the corresponding controls, which increased more than 26‐fold and 32‐fold within 12 days, YY2 overexpression treatment alone limited the growth of both MSI and MSS CRC tumors to 13‐fold or 18‐fold, respectively. This evidence concerns the gene YY2 and colorectal carcinoma.